Santoyo-Olsson, Jasmine Stewart, Anita L Nápoles, Anna María
PurposeAmong Latina breast cancer survivors, explore associations between rural/urban residence and health-related quality of life (HRQL), and whether associations are moderated by financial strain and low neighborhood cohesion.MethodsWe combined baseline data from two randomized controlled trials of a stress management intervention conducted among...
Leslie, Theresa K Tripp, Aurelien James, Andrew D Fraser, Scott P Nelson, Michaela Sajjaboontawee, Nattanan Capatina, Alina L Toss, Michael Fadhil, Wakkas Salvage, Samantha C
...
Solid tumours have abnormally high intracellular [Na+]. The activity of various Na+ channels may underlie this Na+ accumulation. Voltage-gated Na+ channels (VGSCs) have been shown to be functionally active in cancer cell lines, where they promote invasion. However, the mechanisms involved, and clinical relevance, are incompletely understood. Here, ...
AbuHammad, Ala
Breast cancer is the leading cause of death among women and the most frequently diagnosed female cancer worldwide, owing to its complex and heterogenous nature. Despite the intensified research that has been devoted to identifying the best treatment modalities for breast cancer, the mortality rate is still high due to frequent chemoresistance resul...
Ficorella, Lorenzo Yang, Xin Easton, Douglas F Antoniou, Antonis C
Breast cancer risks in older BRCA2 pathogenic variant carriers are understudied. Recent studies show a marked decline in the relative risk at older ages. We used data from two large studies to update the breast cancer risks in the BOADICEA model for BRCA2 carriers 60 years and older. / PPRPGM-Nov20\100002
Luu, Michael Gresham, Gillian Henry, Lynn Kim, Sungjin Rogatko, Andre Yothers, Greg Hays, Ron D Tighiouart, Mourad Ganz, Patricia A
PurposeLongitudinal patient tolerability data collected as part of randomized controlled trials are often summarized in a way that loses information and does not capture the treatment experience. To address this, we developed an interactive web application to empower clinicians and researchers to explore and visualize patient tolerability data.Meth...
Sedrak, Mina S Lee, Minji K Ji, Jingran Satele, Daniel V Freedman, Rachel A Poorvu, Philip D O'Connor, Tracey Williams, Grant R Hopkins, Judith O Muss, Hyman B
...
IntroductionPalbociclib is a widely used treatment for advanced breast cancer in older adults. However, the existing evidence regarding its safety and tolerability in this age group is inconsistent and limited to retrospective subgroup or pooled analyses.Materials and methodsWe conducted a prospective single-arm multicenter phase 2 study to evaluat...
Primm, Kristin M Zhao, Hui Adjei, Naomi N Sun, Charlotte C Haas, Alen Meyer, Larissa A Chang, Shine
BackgroundThe Affordable Care Act expanded Medicaid coverage for people with low income in the United States. Expanded insurance coverage could promote more timely access to cancer treatment, which could improve overall survival (OS), yet the long-term effects of Medicaid expansion (ME) remain unknown. We evaluated whether ME was associated with im...
Fields, Brandon KK Joe, Bonnie N
Shang, Helen Ding, Yi Venkateswaran, Vidhya Boulier, Kristin Kathuria-Prakash, Nikhita Malidarreh, Parisa Boodaghi Luber, Jacob M Pasaniuc, Bogdan
Polygenic scores (PGSs) summarize the combined effect of common risk variants and are associated with breast cancer risk in patients without identifiable monogenic risk factors. One of the most well-validated PGSs in breast cancer to date is PGS313, which was developed from a Northern European biobank but has shown attenuated performance in non-Eur...
Sánchez, Saúl Eduardo Contreras Doubova, Svetlana V Vega, Ingrid Patricia Martinez Álvarez, Rocío Grajales Valencia, Ricardo Villalobos Borunda, Abdel Karim Dip Mondragón, Lorena Lio Pineda, Wendy Jazmín Martínez Cerrillo, Jose Gustavo Nuñez López, Alma Diana Huerta
...
ObjectivesThis study aimed to explore the acceptability, feasibility, usability, and preliminary effect of an electronic patient-reported outcome (ePRO) intervention for patients with breast cancer in Mexico.DesignWe conducted a multimethod non-randomised pilot study. We used a pre-test/post-test design for quantitative assessment of the interventi...